Editorial [ Hot Topic: Highlights on Important Signaling Pathways as Drug Targets in Hematological Malignancies (Guest Editors: H. Serve and H.C. Hasselbalch) ]

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|8|2|203-203

ISSN： 1389-4501

Source： Current Drug Targets, Vol.8, Iss.2, 2007-02, pp. : 203-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot topic: New and Emerging Drug Targets for the Treatment of Hematological Malignancies (Guest Editors: Dr. Linda J. Bendall)]

By  

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 767-768

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Interferon Alpha2 in the Treatment of Hematological Malignancies. Status and Perspectives (Guest Editor: Hans Carl Hasselbalch)]

By  

Current Drug Targets, Vol. 12, Iss. 3, 2011-03 ,pp. : 387-391

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: The Fabisch-Symposium 2009 on Targeted Tumor Therapies(Guest Editors: C. Bachran and H. Fuchs)]

By  

Current Drug Targets, Vol. 10, Iss. 2, 2009-02 ,pp. : 88-88

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [ Hot Topic: Current Drug Targets in Degenerative Joint Disease (Guest Editors: T. Aigner and E. Bartnik) ]

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 269-270

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Current Drug Targets for the Critically Ill COPD Patient (Guest Editors: Demosthenes Makris and Epaminondas Zakynthinos)]

By  

Current Drug Targets, Vol. 12, Iss. 4, 2011-04 ,pp. : 447-449

Bentham Science Publishers

Access to resources Recommend Favorite